Published in J Gen Virol on April 06, 2011
Monitoring Intact Viruses Using Aptamers. Biosensors (Basel) (2016) 0.94
Aptamer-based therapeutics: new approaches to combat human viral diseases. Pharmaceuticals (Basel) (2013) 0.86
Non-specific microbicide product development: then and now. Curr HIV Res (2012) 0.85
Exploiting herpes simplex virus entry for novel therapeutics. Viruses (2013) 0.81
Mycoplasma genitalium promotes epithelial crossing and peripheral blood mononuclear cell infection by HIV-1. Int J Infect Dis (2014) 0.80
Use of Aptamers as Diagnostics Tools and Antiviral Agents for Human Viruses. Pharmaceuticals (Basel) (2016) 0.79
Toggled RNA aptamers against aminoglycosides allowing facile detection of antibiotics using gold nanoparticle assays. Anal Chem (2012) 0.77
Aptamers against pathogenic microorganisms. Crit Rev Microbiol (2015) 0.75
Engineered Aptamers to Probe Molecular Interactions on the Cell Surface. Biomedicines (2017) 0.75
Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res (2003) 77.89
Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol (1999) 41.48
Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 35.96
In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 30.19
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother (2002) 13.91
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS (2006) 10.56
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell (1996) 9.03
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J Virol (2000) 6.71
Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA. Nature (1990) 5.02
Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol (2004) 3.92
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull World Health Organ (2008) 3.62
A mutant T7 RNA polymerase as a DNA polymerase. EMBO J (1995) 2.63
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J Virol (1985) 2.42
Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe (2007) 1.78
Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. Proc Natl Acad Sci U S A (2004) 1.43
Different receptors binding to distinct interfaces on herpes simplex virus gD can trigger events leading to cell fusion and viral entry. Virology (2006) 1.41
Neutralization of infectivity of diverse R5 clinical isolates of human immunodeficiency virus type 1 by gp120-binding 2'F-RNA aptamers. J Virol (2003) 1.37
Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. J Biol Chem (2003) 1.20
Development of aptamer therapeutics. Curr Opin Pharmacol (2010) 1.19
Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men. J Infect Dis (2003) 1.06
Nucleic acid and polypeptide aptamers: a powerful approach to ligand discovery. Curr Opin Pharmacol (2001) 0.92
Protection of HIV neutralizing aptamers against rectal and vaginal nucleases: implications for RNA-based therapeutics. J Biol Chem (2010) 0.92
Production and characterization of RNA aptamers specific for amyloid fibril epitopes. J Biol Chem (2007) 0.90
Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion. J Virol (1972) 17.28
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell (1996) 9.03
Membrane proteins specified by herpes simplex viruses. I. Identification of four glycoprotein precursors and their products in type 1-infected cells. J Virol (1976) 8.73
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
Preparation of herpes simplex virus of high titer. J Virol (1968) 7.64
Initial interaction of herpes simplex virus with cells is binding to heparan sulfate. J Virol (1989) 7.11
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Membrane proteins specified by herpes simplex viruses. III. Role of glycoprotein VP7(B2) in virion infectivity. J Virol (1979) 6.72
Cell fusion induced by herpes simplex virus is promoted and suppressed by different viral glycoproteins. Proc Natl Acad Sci U S A (1977) 5.87
Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J Virol (1979) 5.52
Glycoprotein C of herpes simplex virus type 1 plays a principal role in the adsorption of virus to cells and in infectivity. J Virol (1991) 5.14
Proteins specified by herpes simplex virus. 3. Viruses differing in their effects on the social behavior of infected cells specify different membrane glycoproteins. Proc Natl Acad Sci U S A (1970) 4.97
Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol (1982) 4.74
Proteins specified by herpes simplex virus. VI. Viral proteins in the plasma membrane. J Virol (1972) 4.57
Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1. J Virol (1981) 4.54
Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J Cell Biol (1992) 4.48
Comparison of the virion proteins specified by herpes simplex virus types 1 and 2. J Virol (1975) 4.39
LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity (1998) 4.23
Proteins spcified by herpes simplex virus. II. Viral glycoprotins associated with cellular membranes. J Virol (1970) 4.20
Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proc Natl Acad Sci U S A (1987) 3.96
Herpes simplex virus gene expression in transformed cells. I. Regulation of the viral thymidine kinase gene in transformed L cells by products of superinfecting virus. J Virol (1976) 3.94
Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology (2001) 3.82
O-linked oligosaccharides are acquired by herpes simplex virus glycoproteins in the Golgi apparatus. Cell (1983) 3.73
Crystal structure of an RNA bacteriophage coat protein-operator complex. Nature (1994) 3.65
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. J Clin Invest (2001) 3.64
Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1. Virology (1983) 3.40
Infections with herpes simplex viruses (1). N Engl J Med (1986) 3.26
Neutralizing antibodies specific for glycoprotein H of herpes simplex virus permit viral attachment to cells but prevent penetration. J Virol (1989) 3.20
Immunoglobulin G(Fc)-binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. J Virol (1980) 3.16
Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection. J Virol (1989) 3.09
Glycoprotein D of herpes simplex virus (HSV) binds directly to HVEM, a member of the tumor necrosis factor receptor superfamily and a mediator of HSV entry. J Virol (1997) 3.05
Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J Virol (1998) 3.00
Location of the structural genes for glycoproteins gD and gE and for other polypeptides in the S component of herpes simplex virus type 1 DNA. J Virol (1982) 2.85
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (2001) 2.84
Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B. J Gen Virol (1994) 2.83
Structure and assembly of turnip crinkle virus. II. Mechanism of reassembly in vitro. J Mol Biol (1986) 2.77
Specificities of monoclonal and polyclonal antibodies that inhibit adsorption of herpes simplex virus to cells and lack of inhibition by potent neutralizing antibodies. J Virol (1985) 2.75
Characterization of splenic lymphoid cells in fetal and newborn mice. J Exp Med (1973) 2.75
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
Glycoprotein gE of herpes simplex virus type 1: effects of anti-gE on virion infectivity and on virus-induced fc-binding receptors. J Virol (1982) 2.68
Similarities and differences in the Fc-binding glycoprotein (gE) of herpes simplex virus types 1 and 2 and tentative mapping of the viral gene for this glycoprotein. J Virol (1982) 2.55
The proteins specified by herpes simplex virus. I. Time of synthesis, transfer into nuclei, and properties of proteins made in productively infected cells. Virology (1968) 2.50
Membrane proteins specified by herpes simplex viruses. IV. Conformation of the virion glycoprotein designated VP7(B2). J Virol (1979) 2.47
Potent neutralizing activity associated with anti-glycoprotein D specificity among monoclonal antibodies selected for binding to herpes simplex virions. J Virol (1985) 2.42
Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathway. Virus Res (1991) 2.29
Single amino acid substitutions in gD of herpes simplex virus 1 confer resistance to gD-mediated interference and cause cell-type-dependent alterations in infectivity. Virology (1994) 2.28
Infections with herpes simplex viruses (2). N Engl J Med (1986) 2.22
Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion. J Virol (1984) 2.21
Herpesvirus antigens on cell membranes detected by centrifugation of membrane-antibody complexes. Science (1971) 2.19
The three-dimensional structures of two complexes between recombinant MS2 capsids and RNA operator fragments reveal sequence-specific protein-RNA interactions. J Mol Biol (1997) 2.16
Poly(A) site selection in the HIV-1 provirus: inhibition of promoter-proximal polyadenylation by the downstream major splice donor site. Genes Dev (1995) 2.13
Herpes simplex virus glycoproteins associated with different morphological entities projecting from the virion envelope. J Gen Virol (1987) 2.13
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
Glycoproteins specified by herpes simplex virus type 1: their synthesis, processing and antigenic relatedness to HSV -2 glycoproteins. IARC Sci Publ (1975) 2.10
Size and composition of Marek's disease virus deoxyribonucleic acid. J Virol (1971) 2.10
The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol (1999) 2.03
Maturation of the humoral immune response in mice. J Exp Med (1974) 2.03
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A (1992) 1.96
Oligomerization of herpes simplex virus glycoprotein B. J Virol (1986) 1.91
Cellular expression of alphaherpesvirus gD interferes with entry of homologous and heterologous alphaherpesviruses by blocking access to a shared gD receptor. Virology (2000) 1.91
Physicians promoting bicycle helmets for children: a randomized trial. Am J Public Health (1991) 1.90
The single base pair substitution responsible for the Syn phenotype of herpes simplex virus type 1, strain MP. Virology (1987) 1.80
Urethral insertion of foreign bodies. A report of contagious self-mutilation in a maximum-security hospital. Arch Gen Psychiatry (1982) 1.80
Fine mapping of mutations in the fusion-inducing MP strain of herpes simplex virus type 1. Virology (1984) 1.78
Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med (1987) 1.74
Use of monoclonal antibodies against two 75,000-molecular-weight glycoproteins specified by herpes simplex virus type 2 in glycoprotein identification and gene mapping. J Virol (1983) 1.73
Molecular basis of the glycoprotein-C-negative phenotype of herpes simplex virus type 1 macroplaque strain. J Virol (1984) 1.71
Characterization of a herpes simplex virus type 2 75,000-molecular-weight glycoprotein antigenically related to herpes simplex virus type 1 glycoprotein C. J Virol (1983) 1.69
Alterations in glycoprotein gB specified by mutants and their partial revertants in herpes simplex virus type 1 and relationship to other mutant phenotypes. J Virol (1980) 1.63
Redistribution of nuclear ribonucleoprotein antigens during herpes simplex virus infection. J Cell Biol (1987) 1.61
Crystal structure of an RNA aptamer-protein complex at 2.8 A resolution. Nat Struct Biol (1998) 1.56
Inhibition of heterologous strains of HIV by antisense RNA. AIDS (1991) 1.55
Multiple presentation of foreign peptides on the surface of an RNA-free spherical bacteriophage capsid. J Gen Virol (1993) 1.55
Use of synthetic oligoribonucleotides to probe RNA-protein interactions in the MS2 translational operator complex. Nucleic Acids Res (1990) 1.54
Structural and antigenic analysis of a truncated form of the herpes simplex virus glycoprotein gH-gL complex. J Virol (1998) 1.54
Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry. J Virol (2000) 1.53
Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J Virol (1994) 1.53
Ribosome-mediated folding of partially unfolded ricin A-chain. J Biol Chem (2000) 1.51
Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science (1995) 1.48
Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis. J Virol (1987) 1.46
Characterization of the DNA of herpesviruses associated with Lucké adenocarcinoma of the frog and Burkitt lymphoma of man. Virology (1970) 1.45
Expression of herpes simplex virus glycoprotein C from a DNA fragment inserted into the thymidine kinase gene of this virus. Proc Natl Acad Sci U S A (1982) 1.45
Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res (1994) 1.41
The murine homolog (Mph) of human herpesvirus entry protein B (HveB) mediates entry of pseudorabies virus but not herpes simplex virus types 1 and 2. J Virol (1999) 1.38
Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell. J Immunol (1994) 1.36
Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity. Virology (1996) 1.35
Purification and initial characterization of AhrC: the regulator of arginine metabolism genes in Bacillus subtilis. Mol Microbiol (1992) 1.35
Cooperative tandem binding of met repressor of Escherichia coli. Nature (1989) 1.33
Operator interactions by the Bacillus subtilis arginine repressor/activator, AhrC: novel positioning and DNA-mediated assembly of a transcriptional activator at catabolic sites. Mol Microbiol (1997) 1.32
Structural features of nectin-2 (HveB) required for herpes simplex virus entry. J Virol (2001) 1.30
HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J Virol (1998) 1.27
Limited proteolysis of herpes simplex virus glycoproteins that occurs during their extraction from vero cells. J Virol (1984) 1.27
Proteins specified by herpes simplex virus, IV. Site of glycosylation and accumulation of viral membrane proteins. Proc Natl Acad Sci U S A (1970) 1.26
Crystal structures of a series of RNA aptamers complexed to the same protein target. Nat Struct Biol (1998) 1.26
Transcription from the gene encoding the herpesvirus entry receptor nectin-1 (HveC) in nervous tissue of adult mouse. Virology (2001) 1.25
Evidence for translational regulation of herpes simplex virus type 1 gD expression. J Virol (1984) 1.24
Crystal structures of MS2 coat protein mutants in complex with wild-type RNA operator fragments. Nucleic Acids Res (1998) 1.23
Insertion mutants of herpes simplex virus have a duplication of the glycoprotein D gene and express two different forms of glycoprotein D. J Virol (1983) 1.22